Manabe H et al. |
The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. |
2000 |
Pulm Pharmacol Ther |
pmid:10718985
|
Sun Z et al. |
Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. |
2000 |
Dig Surg |
pmid:10720833
|
Vallee RB et al. |
The role of cytoplasmic dynein in the human brain developmental disease lissencephaly. |
2000 |
Biochim. Biophys. Acta |
pmid:10722879
|
Wang WZ et al. |
Platelet-activating factor contributes to postischemic vasospasm. |
2000 |
J. Surg. Res. |
pmid:10729242
|
Ishii S and Shimizu T |
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. |
2000 |
Prog. Lipid Res. |
pmid:10729607
|
Iglesias-De La Cruz MC et al. |
Phenotypic modifications of human mesangial cells by extracellular matrix: the importance of matrix in the contractile response to reactive oxygen species. |
2000 Mar-Apr |
Exp. Nephrol. |
pmid:10729749
|
Schmidt J et al. |
Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer. |
1999 |
Int. J. Pancreatol. |
pmid:10732294
|
Berthou C et al. |
Interferon-gamma-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis. |
2000 |
Blood |
pmid:10733503
|
Desplat V et al. |
Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. |
2000 |
Cancer Lett. |
pmid:10737702
|
Boccellino M et al. |
Effect of platelet-activating factor receptor expression on CHO cell motility. |
2000 |
J. Cell. Physiol. |
pmid:10737901
|
Hagi A et al. |
Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor. |
2000 |
J. Med. Invest. |
pmid:10740976
|
Tan XD et al. |
Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin. |
2000 |
Br. J. Pharmacol. |
pmid:10742310
|
Wiese A et al. |
Structure-dependent effects of glucose-containing analogs of platelet activating factor (PAF) on membrane integrity. |
2000 |
Biol. Chem. |
pmid:10746745
|
Howard KM and Olson MS |
The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. |
2000 |
J. Biol. Chem. |
pmid:10748027
|
Ruchaud-Sparagano MH et al. |
Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta 2-integrins. Role of tyrosine kinases and Ca2+ mobilization. |
2000 |
J. Biol. Chem. |
pmid:10748085
|
Ibe BO et al. |
Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth. |
2000 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:10749711
|
Koyama S et al. |
The potential of various lipopolysaccharides to release IL-8 and G-CSF. |
2000 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:10749742
|
Martin-Chouly CA et al. |
Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10751643
|
Vincent JL et al. |
Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. |
2000 |
Crit. Care Med. |
pmid:10752807
|
Lendvai N et al. |
Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. |
2000 |
J. Immunol. |
pmid:10754337
|